Vickers Venture Partners

Vickers Venture Partners, established in 2005, is a global venture capital firm headquartered in Singapore. With a focus on deep tech investments, the firm has a proven track record of backing successful companies such as Baidu, Focus Media, and M-Daq, with a combined market value exceeding US$70 billion. Vickers Venture Partners has offices in Singapore, Shanghai, Hong Kong, New York, Miami, Silicon Valley, and London, enabling it to invest worldwide. The firm's partners, including Dr. Finian Tan, have extensive experience in various sectors, including financial services, consumer goods, biotech, and technology.

Kenneth Chew

Director

Poh Hui Chia

Associate Director

Chris Ho

Associate Director

Raymond Kong

CFO

Linda Li

Co-Founder and Venture Partner

Jennifer Qin

Vice President

Vadim Shpak

Operating Managing Director

Finian Tan

Chairman, CIO

Finian Tan

Co-Founder, Managing Director and Member of the Investment Committee

Winnie Xiong

Vice President

60 past transactions

Hyperaccel

Series A in 2024
HyperAccel specializes in hardware solutions tailored for AI application development. The company designs AI-specific semiconductors, optimizing memory bandwidth usage and enhancing cost efficiency, thereby facilitating real-time task completion for businesses.

Mithradote Bio

Seed Round in 2024
Mithradote Bio is a biotechnology company focused on developing a novel sublingual medication to prevent drug-facilitated sexual assault. Their product, a convenient strip for rapid absorption and drug neutralization, empowers potential victims by providing a means to help prevent such assaults when needed.

Aardvark Therapeutics

Series C in 2024
Aardvark Therapeutics, Inc. is a biopharmaceutical company based in San Diego, California, founded in 2017 by Tien Lee. The company focuses on developing and commercializing small molecule therapeutics specifically targeting obesity and rare genetic metabolic disorders. Its lead product, Bittera, is a first-in-class oral composition designed to selectively disrupt hunger signaling while regulating energy homeostasis, providing a novel treatment option that does not interfere with nutrient absorption. Through its innovative approach, Aardvark Therapeutics aims to offer effective and safe solutions for clinicians managing obesity-related diseases.

Eavor

Series B in 2023
Eavor Technologies Inc., established in 2017 and headquartered in Calgary, Canada, specializes in generating industrial-scale electricity using innovative geothermal technology. The company's proprietary system, Eavor-Loop™, harnesses heat from deep within the earth, utilizing wells to produce brine from a subsurface aquifer. This heat is then employed for commercial heating applications and power generation. Eavor's technology mitigates challenges faced by traditional geothermal solutions, offering a clean, carbon-neutral, and scalable baseload power source. The company operates the Eavor-Lite™ Demonstration Project, a prototype of its technology suite, to validate and refine its innovative approach.

Awak

Series B in 2023
AWAK Technologies Inc. is a medical technology company based in Singapore that specializes in the development of wearable dialysis devices for patients with end-stage renal disease. Established in 2008, the company focuses on creating ultraportable dialysis machines that utilize sorbent technology to regenerate and reconstitute used dialysis fluid, effectively providing the necessary clearances for uremic toxins. The Automated Wearable Artificial Kidney (AWAK) is designed to be lightweight, battery-operated, and capable of continuous operation similar to a natural kidney. This innovation allows patients to maintain their daily routines without the restrictions commonly associated with traditional dialysis methods. AWAK Technologies has completed its research and development phase and is currently advancing through clinical trials, aiming for certifications from regulatory bodies. The engineering and development of its products are conducted in collaboration with local educational institutions, underscoring its commitment to innovation in chronic kidney disease management.

Eavor

Series B in 2023
Eavor Technologies Inc., established in 2017 and headquartered in Calgary, Canada, specializes in generating industrial-scale electricity using innovative geothermal technology. The company's proprietary system, Eavor-Loop™, harnesses heat from deep within the earth, utilizing wells to produce brine from a subsurface aquifer. This heat is then employed for commercial heating applications and power generation. Eavor's technology mitigates challenges faced by traditional geothermal solutions, offering a clean, carbon-neutral, and scalable baseload power source. The company operates the Eavor-Lite™ Demonstration Project, a prototype of its technology suite, to validate and refine its innovative approach.

Qianyuhui Environmental Technology Co.

Seed Round in 2022
Beijing Qianyuhui Environmental Technology Co., Ltd. (QYH) was established in 2014 and has been active in the international carbon market since 2016. QYH's core business services include project investment, carbon offset verification consultation, and carbon offset sales. At the same time, we also provide professional consultation services for our clients to help them achieve their carbon neutral goals. QYH has invested in a number of forestry carbon projects in China. We continue to develop more projects at home which aim to help improve the environment and achieve sustainable development of local communities. We at QYH are anticipating continued growth in the voluntary offset market and hope that through market-based mechanisms and nature-based solutions, more people will join us to mitigate the effects of climate change.

RWDC Industries

Series B in 2021
RWDC Industries Ltd is a Singapore-based company that specializes in the development and manufacture of medium chain length polyhydroxyalkanoate (mcl-PHA) biopolymers. Founded in 2015, RWDC produces biodegradable bioplastics suitable for a variety of applications, including food and beverage packaging, cutlery, drinking straws, cup lids, and even diapers. The company’s mcl-PHA biopolymers are derived from the bacterial fermentation of plant-based oils or sugars and are certified to fully biodegrade in soil, water, and marine environments, leaving no toxic residue. RWDC aims to provide sustainable alternatives to single-use plastics, allowing businesses to transition to more environmentally friendly materials while meeting their sustainability goals.

Aardvark Therapeutics

Series B in 2021
Aardvark Therapeutics, Inc. is a biopharmaceutical company based in San Diego, California, founded in 2017 by Tien Lee. The company focuses on developing and commercializing small molecule therapeutics specifically targeting obesity and rare genetic metabolic disorders. Its lead product, Bittera, is a first-in-class oral composition designed to selectively disrupt hunger signaling while regulating energy homeostasis, providing a novel treatment option that does not interfere with nutrient absorption. Through its innovative approach, Aardvark Therapeutics aims to offer effective and safe solutions for clinicians managing obesity-related diseases.

Eavor

Venture Round in 2021
Eavor Technologies Inc., established in 2017 and headquartered in Calgary, Canada, specializes in generating industrial-scale electricity using innovative geothermal technology. The company's proprietary system, Eavor-Loop™, harnesses heat from deep within the earth, utilizing wells to produce brine from a subsurface aquifer. This heat is then employed for commercial heating applications and power generation. Eavor's technology mitigates challenges faced by traditional geothermal solutions, offering a clean, carbon-neutral, and scalable baseload power source. The company operates the Eavor-Lite™ Demonstration Project, a prototype of its technology suite, to validate and refine its innovative approach.

SiSaf

Series B in 2020
SiSaf Ltd. is a biopharmaceutical and drug delivery company based in Guildford, United Kingdom, specializing in RNA delivery and therapeutics. Founded in 2006, the company utilizes its proprietary Bio-Courier technology, which combines organic materials with bioabsorbable silicon, to enhance the stability, safety, and efficiency of RNA therapeutics. SiSaf's portfolio includes silicon-stabilized hybrid lipid nanoparticles designed to address rare genetic disorders, particularly autosomal dominant conditions. The company also offers formulation services and licenses its innovative technologies to clients in various scientific sectors, including pharmaceuticals and biotechnology. With fully integrated research labs and a growing patent estate, SiSaf is positioned to advance its drug development capabilities through strategic partnerships and collaborations, notably with Avellino Labs USA and Croda International.

Chooch

Series A in 2020
Chooch specializes in generative AI technology that integrates computer vision and language understanding to create intelligent camera systems. Their AI Vision platform analyzes video streams in real-time, detecting visuals and actions, comprehending their significance, and triggering pre-programmed responses swiftly. This technology is designed to process a wide range of visual data, from infrared radiation sensors and x-rays to various applications, tagging objects of interest. Chooch's solutions aim to enhance efficiencies and ensure quality results for clients across different industries.

Migo

Series B in 2020
Migo is a company focused on providing affordable access to digital products and services for underserved consumers in emerging markets, particularly in Indonesia. Founded by Barrett Comiskey, a pioneer in digital reading technology, Migo has developed a unique ecosystem that delivers high-bandwidth digital content, including entertainment and educational materials, at a significantly lower cost than traditional networks. Since its launch in Indonesia in 2020, Migo has established over 300 Download Stations, allowing customers to access its services conveniently in their neighborhoods. The company has formed strategic partnerships, notably with MNC Vision Networks, to distribute content and enhance its offerings. By leveraging its proprietary technology, Migo aims to bridge the digital divide, reaching millions of Indonesians and expanding its presence across Java.

MatchMove Pay

Series C in 2020
MatchMove Pay is a Singaporean financial technology company established in 2009, specializing in comprehensive enterprise payment solutions. The company aims to assist businesses in boosting revenue and enhancing customer engagement through its customizable cloud-based platforms. One of its primary offerings is the MatchMove Wallet, an electronic wallet that allows users to manage multiple virtual cards for online shopping. Additionally, MatchMove enables consumer brands, banks, and e-commerce platforms in Asia and emerging markets to issue secure mobile payment cards, facilitating a transparent and secure payment method for customers using smartphones.

Spark Systems

Series B in 2020
Spark Systems, established in 2016 and headquartered in Singapore, specializes in operating an online foreign exchange (FX) trading platform. This FinTech startup, backed by industry veterans, caters primarily to institutional clients, offering a high-tech solution tailored to the unique needs of buy-side subgroups. The company's platform provides a stable, ultra-low latency marketplace, aggregating liquidity and employing algorithms to enhance usability and optimize user experience. This enables diverse participants, including local banks, hedge funds, retail traders, and corporate treasuries, to effectively trade in segmented and under-served FX markets.

RWDC Industries

Series B in 2020
RWDC Industries Ltd is a Singapore-based company that specializes in the development and manufacture of medium chain length polyhydroxyalkanoate (mcl-PHA) biopolymers. Founded in 2015, RWDC produces biodegradable bioplastics suitable for a variety of applications, including food and beverage packaging, cutlery, drinking straws, cup lids, and even diapers. The company’s mcl-PHA biopolymers are derived from the bacterial fermentation of plant-based oils or sugars and are certified to fully biodegrade in soil, water, and marine environments, leaving no toxic residue. RWDC aims to provide sustainable alternatives to single-use plastics, allowing businesses to transition to more environmentally friendly materials while meeting their sustainability goals.

Lumitron Technologies

Venture Round in 2020
Lumitron Technologies specializes in the development and commercialization of advanced X-ray and laser technologies aimed at enhancing medical imaging and therapeutic procedures. The company leverages an innovative X-ray technique created in collaboration with Lawrence Livermore National Laboratory and the SLAC National Accelerator Laboratory at Stanford University. This technique employs a novel high-energy laser light source, known as Laser-Compton, allowing for the creation of compact X-ray systems that can deliver high-fidelity imaging and ultra-low dose radiography, all within the size of a modern CT scanner. Lumitron's technology is designed to replace traditional X-ray and CT scanners, providing healthcare providers with enhanced capabilities for detailed tumor identification and enabling ultra-precision radiotherapy while simultaneously imaging. Additionally, the systems support element-specific and isotope-specific material identification, facilitating advanced imaging and targeted therapies directly in clinical settings.

Emergex Vaccines

Series A in 2020
Emergex Vaccines Holding Ltd is a biotechnology company based in Abingdon, United Kingdom, focused on the research and development of vaccines targeting viral and bacterial infectious diseases. Founded in 2016, the company specializes in creating innovative set-point vaccines that utilize synthetic non-biological components to activate immune cells capable of eliminating pathogen-infected cells. Emergex Vaccines aims to provide affordable and effective vaccine solutions, particularly for low-resource environments that are disproportionately affected by pandemics. Their vaccine portfolio includes candidates for diseases such as dengue, influenza, Zika, hepatitis B, Ebola, and serious intracellular bacterial infections. Additionally, the company is working to establish a clinical-grade international vaccine repository, which will serve as a first line of defense during outbreaks of both existing and emerging infectious diseases.

Chooch

Convertible Note in 2019
Chooch specializes in generative AI technology that integrates computer vision and language understanding to create intelligent camera systems. Their AI Vision platform analyzes video streams in real-time, detecting visuals and actions, comprehending their significance, and triggering pre-programmed responses swiftly. This technology is designed to process a wide range of visual data, from infrared radiation sensors and x-rays to various applications, tagging objects of interest. Chooch's solutions aim to enhance efficiencies and ensure quality results for clients across different industries.

Awak

Series A in 2019
AWAK Technologies Inc. is a medical technology company based in Singapore that specializes in the development of wearable dialysis devices for patients with end-stage renal disease. Established in 2008, the company focuses on creating ultraportable dialysis machines that utilize sorbent technology to regenerate and reconstitute used dialysis fluid, effectively providing the necessary clearances for uremic toxins. The Automated Wearable Artificial Kidney (AWAK) is designed to be lightweight, battery-operated, and capable of continuous operation similar to a natural kidney. This innovation allows patients to maintain their daily routines without the restrictions commonly associated with traditional dialysis methods. AWAK Technologies has completed its research and development phase and is currently advancing through clinical trials, aiming for certifications from regulatory bodies. The engineering and development of its products are conducted in collaboration with local educational institutions, underscoring its commitment to innovation in chronic kidney disease management.

Aardvark Therapeutics

Series A in 2019
Aardvark Therapeutics, Inc. is a biopharmaceutical company based in San Diego, California, founded in 2017 by Tien Lee. The company focuses on developing and commercializing small molecule therapeutics specifically targeting obesity and rare genetic metabolic disorders. Its lead product, Bittera, is a first-in-class oral composition designed to selectively disrupt hunger signaling while regulating energy homeostasis, providing a novel treatment option that does not interfere with nutrient absorption. Through its innovative approach, Aardvark Therapeutics aims to offer effective and safe solutions for clinicians managing obesity-related diseases.

M-DAQ

Venture Round in 2019
M-DAQ Pte Ltd is an innovative company that specializes in providing a platform for cross-border transactions, enabling users to price and trade exchange-traded products in multiple currencies. Founded by industry veterans with extensive experience in foreign exchange and securities, M-DAQ blends executable foreign exchange rates into equities and futures products. This unique solution allows traders and security exchanges to operate in a multi-currency environment without requiring significant changes to their existing systems and back-end processes. M-DAQ maintains key relationships with national exchanges and global foreign exchange banks and handles the consultancy work necessary for exchanges to utilize its solution. Additionally, partner exchanges can earn revenue through a share of the net foreign exchange margins generated by the platform, all while operating within their respective regulatory frameworks.

MatchMove Pay

Series B in 2019
MatchMove Pay is a Singaporean financial technology company established in 2009, specializing in comprehensive enterprise payment solutions. The company aims to assist businesses in boosting revenue and enhancing customer engagement through its customizable cloud-based platforms. One of its primary offerings is the MatchMove Wallet, an electronic wallet that allows users to manage multiple virtual cards for online shopping. Additionally, MatchMove enables consumer brands, banks, and e-commerce platforms in Asia and emerging markets to issue secure mobile payment cards, facilitating a transparent and secure payment method for customers using smartphones.

Skyroam

Series C in 2019
Skyroam was founded in Silicon Valley by technology veterans who have identified a common point of pain among fellow business travelers: getting a fast, reliable mobile internet connection while on the road is a challenge. And when returning home, the traveler invariably receives a shockingly high roaming bill. This problem is becoming more acute as data consumption skyrockets, driven by smartphones, tablets, netbooks, and even wearables. Skyroam’s solution to this problem is 3GMate, a global mobile hotspot that provides easy, fast, secure and affordable mobile data around the world. 3Gmate keeps you connected on the road; keeps your corporate data secure; and drives efficiency into your company’s BYOD program. The next step for Skyroam is to power the Internet of Things. By leveraging our patented virtual SIM technology, Skyroam delivers a local SIM over the air to ensure a seamless data connection around the world for your IoT application. Skyroam’s vSIM technology enables companies in the wireless ecosystem to easily deploy mobile connectivity anywhere in the world, simplifying supply chain, reducing costs, and improving service levels.

Eavor

Series A in 2019
Eavor Technologies Inc., established in 2017 and headquartered in Calgary, Canada, specializes in generating industrial-scale electricity using innovative geothermal technology. The company's proprietary system, Eavor-Loop™, harnesses heat from deep within the earth, utilizing wells to produce brine from a subsurface aquifer. This heat is then employed for commercial heating applications and power generation. Eavor's technology mitigates challenges faced by traditional geothermal solutions, offering a clean, carbon-neutral, and scalable baseload power source. The company operates the Eavor-Lite™ Demonstration Project, a prototype of its technology suite, to validate and refine its innovative approach.

Everledger

Series A in 2019
Everledger Limited is a technology enterprise based in London, established in 2015, that specializes in the digitization and tracking of high-value assets using blockchain technology. The company creates a multi-layered digital ledger that enhances transparency and traceability across global supply chains, specifically focusing on industries such as diamonds and luxury goods. By integrating innovative technologies, such as smart contracts and machine vision, Everledger enables stakeholders to collaborate within an ecosystem built on trust, allowing for the secure management of assets throughout their lifecycle. This forensic approach to asset provenance not only combats fraud but also ensures compliance with industry standards. Everledger's commitment to deploying scalable solutions addresses contemporary economic, environmental, and societal challenges, fostering confidence among manufacturers, jewelry retailers, and other participants in the market.

SiSaf

Series A in 2019
SiSaf Ltd. is a biopharmaceutical and drug delivery company based in Guildford, United Kingdom, specializing in RNA delivery and therapeutics. Founded in 2006, the company utilizes its proprietary Bio-Courier technology, which combines organic materials with bioabsorbable silicon, to enhance the stability, safety, and efficiency of RNA therapeutics. SiSaf's portfolio includes silicon-stabilized hybrid lipid nanoparticles designed to address rare genetic disorders, particularly autosomal dominant conditions. The company also offers formulation services and licenses its innovative technologies to clients in various scientific sectors, including pharmaceuticals and biotechnology. With fully integrated research labs and a growing patent estate, SiSaf is positioned to advance its drug development capabilities through strategic partnerships and collaborations, notably with Avellino Labs USA and Croda International.

MatchMove Pay

Series B in 2019
MatchMove Pay is a Singaporean financial technology company established in 2009, specializing in comprehensive enterprise payment solutions. The company aims to assist businesses in boosting revenue and enhancing customer engagement through its customizable cloud-based platforms. One of its primary offerings is the MatchMove Wallet, an electronic wallet that allows users to manage multiple virtual cards for online shopping. Additionally, MatchMove enables consumer brands, banks, and e-commerce platforms in Asia and emerging markets to issue secure mobile payment cards, facilitating a transparent and secure payment method for customers using smartphones.

RWDC Industries

Series A in 2019
RWDC Industries Ltd is a Singapore-based company that specializes in the development and manufacture of medium chain length polyhydroxyalkanoate (mcl-PHA) biopolymers. Founded in 2015, RWDC produces biodegradable bioplastics suitable for a variety of applications, including food and beverage packaging, cutlery, drinking straws, cup lids, and even diapers. The company’s mcl-PHA biopolymers are derived from the bacterial fermentation of plant-based oils or sugars and are certified to fully biodegrade in soil, water, and marine environments, leaving no toxic residue. RWDC aims to provide sustainable alternatives to single-use plastics, allowing businesses to transition to more environmentally friendly materials while meeting their sustainability goals.

Chooch

Seed Round in 2019
Chooch specializes in generative AI technology that integrates computer vision and language understanding to create intelligent camera systems. Their AI Vision platform analyzes video streams in real-time, detecting visuals and actions, comprehending their significance, and triggering pre-programmed responses swiftly. This technology is designed to process a wide range of visual data, from infrared radiation sensors and x-rays to various applications, tagging objects of interest. Chooch's solutions aim to enhance efficiencies and ensure quality results for clients across different industries.

Fastwork

Series A in 2018
Fastwork, founded in 2015 by a team of engineers and entrepreneurs from Silicon Valley and New York, is a prominent freelancing platform in Southeast Asia, recognized for its extensive user base and project completions. The company aims to enhance the business and employment landscape in the region by providing a simple, efficient, and cost-effective solution for businesses seeking freelancers. With over 300,000 businesses utilizing its platform, Fastwork offers a diverse range of services, including graphic design, online marketing, data entry, and web and app development. The platform not only connects clients with suitable freelancers for short-term projects but also facilitates essential tools for freelancers, such as payment collection, service promotion, order management, file exchange, and client communication, enabling seamless collaboration anytime and anywhere.

RWDC Industries

Series A in 2018
RWDC Industries Ltd is a Singapore-based company that specializes in the development and manufacture of medium chain length polyhydroxyalkanoate (mcl-PHA) biopolymers. Founded in 2015, RWDC produces biodegradable bioplastics suitable for a variety of applications, including food and beverage packaging, cutlery, drinking straws, cup lids, and even diapers. The company’s mcl-PHA biopolymers are derived from the bacterial fermentation of plant-based oils or sugars and are certified to fully biodegrade in soil, water, and marine environments, leaving no toxic residue. RWDC aims to provide sustainable alternatives to single-use plastics, allowing businesses to transition to more environmentally friendly materials while meeting their sustainability goals.

MatchMove Pay

Series B in 2018
MatchMove Pay is a Singaporean financial technology company established in 2009, specializing in comprehensive enterprise payment solutions. The company aims to assist businesses in boosting revenue and enhancing customer engagement through its customizable cloud-based platforms. One of its primary offerings is the MatchMove Wallet, an electronic wallet that allows users to manage multiple virtual cards for online shopping. Additionally, MatchMove enables consumer brands, banks, and e-commerce platforms in Asia and emerging markets to issue secure mobile payment cards, facilitating a transparent and secure payment method for customers using smartphones.

Biosplice Therapeutics

Series B in 2018
Biosplice Therapeutics is a company focused on medical research and development in tissue-level regeneration. Its platform, which originated from small molecule-based modulation of the Wnt signaling pathway, is designed to create therapeutics for a variety of degenerative diseases, including osteoarthritis and certain cancers. By discovering new biological targets and processes, Biosplice Therapeutics aims to develop innovative small molecule drugs that could provide curative therapies for multiple conditions. The company's objective is to enhance patient health through a comprehensive technology platform dedicated to modulating regenerative pathways.

Icontek

Series A in 2018
Icontek, established in 2014 and based in Toronto, Canada, specializes in developing advanced natural language processing and machine learning systems. The company's core products, Tennis Text and Tennis Voice, facilitate seamless, natural conversations between users and brands via chat and voice platforms. By enabling fluid interactions between users, machines, and systems, Icontek empowers businesses to provide 24/7 customer support, engagement, and recruitment through virtual assistants, chatbots, and voice bots.

SiSaf

Series A in 2018
SiSaf Ltd. is a biopharmaceutical and drug delivery company based in Guildford, United Kingdom, specializing in RNA delivery and therapeutics. Founded in 2006, the company utilizes its proprietary Bio-Courier technology, which combines organic materials with bioabsorbable silicon, to enhance the stability, safety, and efficiency of RNA therapeutics. SiSaf's portfolio includes silicon-stabilized hybrid lipid nanoparticles designed to address rare genetic disorders, particularly autosomal dominant conditions. The company also offers formulation services and licenses its innovative technologies to clients in various scientific sectors, including pharmaceuticals and biotechnology. With fully integrated research labs and a growing patent estate, SiSaf is positioned to advance its drug development capabilities through strategic partnerships and collaborations, notably with Avellino Labs USA and Croda International.

Everledger

Series A in 2018
Everledger Limited is a technology enterprise based in London, established in 2015, that specializes in the digitization and tracking of high-value assets using blockchain technology. The company creates a multi-layered digital ledger that enhances transparency and traceability across global supply chains, specifically focusing on industries such as diamonds and luxury goods. By integrating innovative technologies, such as smart contracts and machine vision, Everledger enables stakeholders to collaborate within an ecosystem built on trust, allowing for the secure management of assets throughout their lifecycle. This forensic approach to asset provenance not only combats fraud but also ensures compliance with industry standards. Everledger's commitment to deploying scalable solutions addresses contemporary economic, environmental, and societal challenges, fostering confidence among manufacturers, jewelry retailers, and other participants in the market.

Skyroam

Series C in 2018
Skyroam was founded in Silicon Valley by technology veterans who have identified a common point of pain among fellow business travelers: getting a fast, reliable mobile internet connection while on the road is a challenge. And when returning home, the traveler invariably receives a shockingly high roaming bill. This problem is becoming more acute as data consumption skyrockets, driven by smartphones, tablets, netbooks, and even wearables. Skyroam’s solution to this problem is 3GMate, a global mobile hotspot that provides easy, fast, secure and affordable mobile data around the world. 3Gmate keeps you connected on the road; keeps your corporate data secure; and drives efficiency into your company’s BYOD program. The next step for Skyroam is to power the Internet of Things. By leveraging our patented virtual SIM technology, Skyroam delivers a local SIM over the air to ensure a seamless data connection around the world for your IoT application. Skyroam’s vSIM technology enables companies in the wireless ecosystem to easily deploy mobile connectivity anywhere in the world, simplifying supply chain, reducing costs, and improving service levels.

Alo7

Series D in 2017
ALO7 is the largest digital English Language Teaching (ELT) product and solutions provider in China, boasting over 10 million registered users and more than 2,000 training school partners. The company operates an online tutoring platform designed to support young Chinese students in learning English. By leveraging technology, ALO7 facilitates interactions among students, teachers, parents, and school administrators, thereby enhancing both online and offline educational experiences. The platform offers fun and interactive classes that blend education with play, ensuring high-quality teaching products and services are accessible to schools and learners alike. Through its innovative approach, ALO7 is transforming the landscape of English language education in China.

Snapcart

Series A in 2017
Snapcart is a cashback application based in Indonesia that rewards consumers for scanning their receipts. By incentivizing users to take photos of their purchase receipts, the app collects valuable data on consumer behavior, offering brands and retailers more accurate insights than traditional research methods. This real-time data enables businesses to connect with shoppers on a personalized level, enhancing brand engagement through targeted marketing strategies. Snapcart's innovative approach combines consumer rewards with crowd-sourced information, allowing clients to better understand and engage with their target audience.

Altibbi

Series B in 2017
Altibbi Ltd. is a digital health platform based in Dubai, United Arab Emirates, that connects users with healthcare information and services throughout the Middle East. Founded in 2008, Altibbi offers a comprehensive range of resources, including medical articles, videos, a medical dictionary, and an encyclopedia of medicines. The platform addresses various health topics, such as chronic diseases, allergies, and dental issues, providing users with the knowledge they need to make informed health decisions. In addition to informational resources, Altibbi facilitates access to healthcare by allowing users to book appointments with qualified doctors via video calls and translating medical terminology into Arabic. The platform is accessible 24/7 through its website and mobile applications, enhancing healthcare access and quality for users in the region.

SiSaf

Series A in 2017
SiSaf Ltd. is a biopharmaceutical and drug delivery company based in Guildford, United Kingdom, specializing in RNA delivery and therapeutics. Founded in 2006, the company utilizes its proprietary Bio-Courier technology, which combines organic materials with bioabsorbable silicon, to enhance the stability, safety, and efficiency of RNA therapeutics. SiSaf's portfolio includes silicon-stabilized hybrid lipid nanoparticles designed to address rare genetic disorders, particularly autosomal dominant conditions. The company also offers formulation services and licenses its innovative technologies to clients in various scientific sectors, including pharmaceuticals and biotechnology. With fully integrated research labs and a growing patent estate, SiSaf is positioned to advance its drug development capabilities through strategic partnerships and collaborations, notably with Avellino Labs USA and Croda International.

Snapcart

Seed Round in 2017
Snapcart is a cashback application based in Indonesia that rewards consumers for scanning their receipts. By incentivizing users to take photos of their purchase receipts, the app collects valuable data on consumer behavior, offering brands and retailers more accurate insights than traditional research methods. This real-time data enables businesses to connect with shoppers on a personalized level, enhancing brand engagement through targeted marketing strategies. Snapcart's innovative approach combines consumer rewards with crowd-sourced information, allowing clients to better understand and engage with their target audience.

Spark Systems

Venture Round in 2016
Spark Systems, established in 2016 and headquartered in Singapore, specializes in operating an online foreign exchange (FX) trading platform. This FinTech startup, backed by industry veterans, caters primarily to institutional clients, offering a high-tech solution tailored to the unique needs of buy-side subgroups. The company's platform provides a stable, ultra-low latency marketplace, aggregating liquidity and employing algorithms to enhance usability and optimize user experience. This enables diverse participants, including local banks, hedge funds, retail traders, and corporate treasuries, to effectively trade in segmented and under-served FX markets.

GuavaPass

Series A in 2016
GuavaPass is a fitness platform that connects individuals with gyms, fitness studios, and healthy-living experts across several major cities, including Bangkok, Beijing, Dubai, Hong Kong, Jakarta, Manila, Seoul, Shanghai, Singapore, and Taipei. Founded in April 2015 by Jeffrey Liu and Robert Pachter, the company offers access to a diverse range of fitness classes, including yoga, kickboxing, spinning, dance, CrossFit, and Pilates, allowing users to engage in various fitness activities in an enjoyable manner. Headquartered in Singapore, GuavaPass aims to facilitate optimum fitness through its comprehensive network of boutique studios and fitness offerings. The company was acquired by ClassPass in January 2019.

SiSaf

Series A in 2016
SiSaf Ltd. is a biopharmaceutical and drug delivery company based in Guildford, United Kingdom, specializing in RNA delivery and therapeutics. Founded in 2006, the company utilizes its proprietary Bio-Courier technology, which combines organic materials with bioabsorbable silicon, to enhance the stability, safety, and efficiency of RNA therapeutics. SiSaf's portfolio includes silicon-stabilized hybrid lipid nanoparticles designed to address rare genetic disorders, particularly autosomal dominant conditions. The company also offers formulation services and licenses its innovative technologies to clients in various scientific sectors, including pharmaceuticals and biotechnology. With fully integrated research labs and a growing patent estate, SiSaf is positioned to advance its drug development capabilities through strategic partnerships and collaborations, notably with Avellino Labs USA and Croda International.

MatchMove Pay

Series A in 2016
MatchMove Pay is a Singaporean financial technology company established in 2009, specializing in comprehensive enterprise payment solutions. The company aims to assist businesses in boosting revenue and enhancing customer engagement through its customizable cloud-based platforms. One of its primary offerings is the MatchMove Wallet, an electronic wallet that allows users to manage multiple virtual cards for online shopping. Additionally, MatchMove enables consumer brands, banks, and e-commerce platforms in Asia and emerging markets to issue secure mobile payment cards, facilitating a transparent and secure payment method for customers using smartphones.

Skyroam

Series B in 2015
Skyroam was founded in Silicon Valley by technology veterans who have identified a common point of pain among fellow business travelers: getting a fast, reliable mobile internet connection while on the road is a challenge. And when returning home, the traveler invariably receives a shockingly high roaming bill. This problem is becoming more acute as data consumption skyrockets, driven by smartphones, tablets, netbooks, and even wearables. Skyroam’s solution to this problem is 3GMate, a global mobile hotspot that provides easy, fast, secure and affordable mobile data around the world. 3Gmate keeps you connected on the road; keeps your corporate data secure; and drives efficiency into your company’s BYOD program. The next step for Skyroam is to power the Internet of Things. By leveraging our patented virtual SIM technology, Skyroam delivers a local SIM over the air to ensure a seamless data connection around the world for your IoT application. Skyroam’s vSIM technology enables companies in the wireless ecosystem to easily deploy mobile connectivity anywhere in the world, simplifying supply chain, reducing costs, and improving service levels.

MatchMove Pay

Seed Round in 2013
MatchMove Pay is a Singaporean financial technology company established in 2009, specializing in comprehensive enterprise payment solutions. The company aims to assist businesses in boosting revenue and enhancing customer engagement through its customizable cloud-based platforms. One of its primary offerings is the MatchMove Wallet, an electronic wallet that allows users to manage multiple virtual cards for online shopping. Additionally, MatchMove enables consumer brands, banks, and e-commerce platforms in Asia and emerging markets to issue secure mobile payment cards, facilitating a transparent and secure payment method for customers using smartphones.

Biosplice Therapeutics

Series A in 2013
Biosplice Therapeutics is a company focused on medical research and development in tissue-level regeneration. Its platform, which originated from small molecule-based modulation of the Wnt signaling pathway, is designed to create therapeutics for a variety of degenerative diseases, including osteoarthritis and certain cancers. By discovering new biological targets and processes, Biosplice Therapeutics aims to develop innovative small molecule drugs that could provide curative therapies for multiple conditions. The company's objective is to enhance patient health through a comprehensive technology platform dedicated to modulating regenerative pathways.

Alo7

Series C in 2013
ALO7 is the largest digital English Language Teaching (ELT) product and solutions provider in China, boasting over 10 million registered users and more than 2,000 training school partners. The company operates an online tutoring platform designed to support young Chinese students in learning English. By leveraging technology, ALO7 facilitates interactions among students, teachers, parents, and school administrators, thereby enhancing both online and offline educational experiences. The platform offers fun and interactive classes that blend education with play, ensuring high-quality teaching products and services are accessible to schools and learners alike. Through its innovative approach, ALO7 is transforming the landscape of English language education in China.

MatchMove Pay

Seed Round in 2012
MatchMove Pay is a Singaporean financial technology company established in 2009, specializing in comprehensive enterprise payment solutions. The company aims to assist businesses in boosting revenue and enhancing customer engagement through its customizable cloud-based platforms. One of its primary offerings is the MatchMove Wallet, an electronic wallet that allows users to manage multiple virtual cards for online shopping. Additionally, MatchMove enables consumer brands, banks, and e-commerce platforms in Asia and emerging markets to issue secure mobile payment cards, facilitating a transparent and secure payment method for customers using smartphones.

24 Quan

Series A in 2011
24 Quan (24券) is an e-commerce website focused on group purchasing. It was launched by Beijing Hongweibo Culture and Art Co., Ltd. 24 Quan provides only one daily boutique item, including various sites for consumptions such as Chinese and Western restaurants, theaters, concerts, bars, hair and body salons, KTV, nightclubs, outdoor sports, tourism, sports events and physical fitness, and more. When the number of buyers reach the minimum for grouping, the dealers and the stores offer discounts. As an organizer of the existing business mode, 24 Quan reduces the overall cost of consumption and hands out these discounts to each customer in group-buying through scale effects.

Lotaris

Series A in 2011
Lotaris, a Red Herring Global 100 Award Winner, is a global independent in-app commerce provider offering developers the most comprehensive suite of services to support their monetization needs. Delivering apps and services to millions of users on behalf of large enterprise software vendors, Lotaris solutions are also available for smaller independent developers and game publishers through its in-appCommerce service. Lotaris supports all major open platforms, in-app business models for both purchasing and advertising through any channel, and all major payment methods integrated seamlessly on one award-winning platform. Based in San Francisco, Switzerland, Singapore and Tokyo, Lotaris provides services world-wide for customers and partners including Microsoft, Symantec, Sega, Capcom, Digital River and others. For more details, visit http://lotaris.com.

Beijing Tenfen Science and Technology

Series A in 2010
Beijing Tenfen Technology Co., Ltd. is a high-tech enterprise based in Beijing, China, specializing in the publication and integration of digital content, particularly for electronic reading platforms. The company serves notable clients, including China Telecom and China Unicom, and provides design, marketing, and operational support tailored for digital reading products. Tenfen has developed several products, including Kuyun Reading, which utilizes intelligent semantic analysis and personalized recommendation algorithms to enhance user experience. Additionally, the company offers an electronic book platform that encompasses digital content, mobile games, and mobile Internet payment services. Through its diverse offerings, Tenfen aims to meet the evolving demands of consumers in the digital content landscape.

MatchMove Pay

Seed Round in 2009
MatchMove Pay is a Singaporean financial technology company established in 2009, specializing in comprehensive enterprise payment solutions. The company aims to assist businesses in boosting revenue and enhancing customer engagement through its customizable cloud-based platforms. One of its primary offerings is the MatchMove Wallet, an electronic wallet that allows users to manage multiple virtual cards for online shopping. Additionally, MatchMove enables consumer brands, banks, and e-commerce platforms in Asia and emerging markets to issue secure mobile payment cards, facilitating a transparent and secure payment method for customers using smartphones.

Net Power Technology

Series A in 2008
Net Power Technology is dedicated to promoting green energy and advancing energy conservation and environmental protection initiatives. The company collaborates with leading professionals from both domestic and international backgrounds and partners with prestigious academic institutions, including the Chinese Academy of Sciences and Tsinghua University. Net Power Technology holds several patents related to flow battery energy storage systems, showcasing its commitment to innovation in the energy sector. Through these efforts, the company aims to contribute significantly to sustainable energy solutions.

Fix8

Series A in 2007
[Fix8](http://www.fix8.com) is a communication application that allows people to customize their on-screen virtual appearance in real-time using avatar technology and creative accessories. Fix8 integrates human expression analysis and rendering capabilities, avatar/facial sculpting and animation technology, voice manipulation, and one click 3D facemaker design capabilities in one package. The program can create live streaming enhanced video to integrate into IM or other broadcast (such as TV) experiences, or record still images and fully-rendered videos. Fix8 aims to enhance the communication experience of its clients' customers by breathing new life into digital channels across multiple mediums. via: [Fix8](http://www.fix8.com)

Alo7

Series B in 2007
ALO7 is the largest digital English Language Teaching (ELT) product and solutions provider in China, boasting over 10 million registered users and more than 2,000 training school partners. The company operates an online tutoring platform designed to support young Chinese students in learning English. By leveraging technology, ALO7 facilitates interactions among students, teachers, parents, and school administrators, thereby enhancing both online and offline educational experiences. The platform offers fun and interactive classes that blend education with play, ensuring high-quality teaching products and services are accessible to schools and learners alike. Through its innovative approach, ALO7 is transforming the landscape of English language education in China.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.